51. 全身性強皮症 Scleroderma Clinical trials / Disease details

臨床試験数 : 525 / 薬物数 : 565 - (DrugBank : 148) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 217

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04837131 (ClinicalTrials.gov)	April 28, 2021	5/4/2021	A Study to Evaluate the Safety and Tolerability of Oral Ixazomibin Scleroderma-related Lung Disease ...	A Phase 2 Open-Label Pilot Study of the Safety and Tolerability of IxazomibAdministered Orally to Pa ...	Systemic Sclerosis;Scleroderma;Diffuse Systemic Sclerosis;Diffuse Scleroderma;Diffuse Cutaneous Syst ...	Drug: Ixazomib	W. Leroy Griffing	NULL	Recruiting	18 Years	N/A	All	12	Phase 2	United States

First Previous1Next Last